Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$9.29B
Net Profit Margin
-2.03%
TTM Avg
1.55%
3Y Avg
7.31%
5Y Avg
8.11%
Market Cap
$9.71B
Net Profit Margin
54.82%
TTM Avg
41.66%
3Y Avg
26.22%
5Y Avg
17.48%
Market Cap
$9.71B
Net Profit Margin
2.96%
TTM Avg
3.05%
3Y Avg
3.43%
5Y Avg
3.79%
Market Cap
$9.00B
Net Profit Margin
-2.03%
TTM Avg
1.55%
3Y Avg
7.31%
5Y Avg
8.11%
Market Cap
$8.99B
Net Profit Margin
-24.68%
TTM Avg
-51.58%
3Y Avg
-141.39%
5Y Avg
-94.26%
Market Cap
$8.88B
Net Profit Margin
29.40%
TTM Avg
-109.74%
3Y Avg
-207.58%
5Y Avg
-253.39%
Market Cap
$9.98B
Net Profit Margin
8.59%
TTM Avg
-21.22%
3Y Avg
-48.94%
5Y Avg
16.61%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.51B | 0.00% | 0.00% | 0.00% | 0.00% |
| Insulet Corp. (PODD)vs › | $9.39B | 12.29% | 14.66% | 10.46% | 7.35% |
| Bruker Corporation (BRKR)vs › | $9.29B | -2.03% | 1.55% | 7.31% | 8.11% |
| Krystal Biotech, Inc. (KRYS)vs › | $9.71B | 54.82% | 41.66% | 26.22% | 17.48% |
| Henry Schein, Inc. (HSIC)vs › | $9.71B | 2.96% | 3.05% | 3.43% | 3.79% |
| Bruker Corporation (BRKRP)vs › | $9.00B | -2.03% | 1.55% | 7.31% | 8.11% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.99B | -24.68% | -51.58% | -141.39% | -94.26% |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.88B | 29.40% | -109.74% | -207.58% | -253.39% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.98B | 8.59% | -21.22% | -48.94% | 16.61% |
| Repligen Corporation (RGEN)vs › | $10.01B | 5.29% | 1.30% | 7.86% | 11.15% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
